Page 158 - Read Online
P. 158

Grewal et al. Art Int Surg 2023;3:217-32  https://dx.doi.org/10.20517/ais.2023.28   Page 225

               Table 1. Current limitations of radiomics
                No.  Limitations
                1   Limited validation of radiomics models
                2   Segmentation required with most literature based on manual segmentation techniques
                    (1) Operator dependent
                    (2) Time intensive
                    (3) Introduces inherent variation that radiomic features may be sensitive to
                3   Lack of standardization in the workflow of radiomics
                4   Radiomics features are sensitive to variations in imaging protocols, which limits multicentric generalization


               Most literature on radiomics is based on manually segmented datasets. Manual segmentation introduces
                                                       [22]
               human error and is highly operator-dependent . In the case of hepatobiliary and pancreatic malignancies,
               particularly pancreatic cancer, these tumors have irregular boundaries, which makes segmentation even
               more difficult. Although variations in segmentation methods have been linked to introducing specific
               differences in radiomic signatures, no current consensus exists on the segmentation techniques. Deep-
               learning-based segmentation has shown promise in bridging this gap; however, it depends on the
               accumulation of large datasets to train these models. Work is underway; however, this has not yet been
               achieved. Additionally, manual segmentation is time-intensive and requires oversight by trained
               radiologists, thus hampering the feasibility of using it in the clinical setting. Third, in order to eliminate bias,
               mitigate confounding factors, and encourage reproducibility, the radiomics workflow of studies should be
               scrutinized and entirely standardized. Many current studies have ambiguous descriptions regarding their
               process of feature extraction algorithms, mathematical definitions, inconsistencies in feature nomenclature
                                           [130]
               and pre-processing methodology . This has been the source of skepticism from clinicians who perceive
               the radiomics model as a black box that generates satisfying clinical prediction results for any given clinical
                       [130]
               outcome . Moving forwards, a clear and transparent description of all these processes, alongside any
               feature reduction or exclusion, should be attempted. Lastly, radiomic features have been demonstrated to be
               sensitive to variations in image acquisition protocols [22,131] . Even variations in the time at which contrast-
               enhanced images are captured following the administration of contrast have been shown to significantly
               affect the radiomic features of acquired images . Due to this, imaging protocols must be standardized
                                                        [132]
               across all centers evaluating radiomics. Efforts are underway to address these shortcomings, one example of
               which is the introduction of the radiomics quality score (RQS), a generalizable tool to assess the quality of
                                                                                      [133]
               radiomic studies, which is now being integrated into a majority of studies in the field .

               FUTURE DIRECTIONS AND CLINICAL INTEGRATION
               Despite limitations, current results of radiomics-based studies are encouraging and denote a promising
               future for the field. As the radiomics workflow becomes more standardized and the radiomics process
               becomes more  easily  reproducible,  significant  clinical  implications  can  be  expected  in  the  following
               domains.


               As a screening tool, radiomics has already demonstrated significant potential in differentiating normal
               tissue from malignancy. With currently ongoing work on automated deep learning-based radiomics
               workflow, it can be expected that tools that can accurately screen for hepatobiliary and pancreatic
               malignancies will be developed. Upon validation, these can then be made available for widespread clinical
               integration. This tool could be run on radiographic images to autonomously highlight suspicious areas of
               interest and bring them to the attention of a reading radiologist, providing a probability assessment of
               potential early malignancy.
   153   154   155   156   157   158   159   160   161   162   163